Technical Analysis Based on recent price action, BUD is showing bearish momentum with RSI at 45.85 indicating neutral to slightly oversold conditions. The MACD at -1.19 suggests a bearish trend continuation. The stock is trading below its 20-day SMA of $48.54, indicating near-term weakness.
News Impact Recent analyst coverage remains mixed. Kepler Capital maintains a Buy rating with €66.00 target while Deutsche Bank holds a Hold rating. The stock has underperformed the broader market, with recent trading sessions showing weakness.
Price Projection for Next Week Based on Fibonacci levels and technical indicators:
The stock is likely to trade between $45.50-$48.00 next week. Key factors:
Trading Recommendation SELL with target entry at $47.40-$48.00 range. Set stop loss at $49.00. Rationale:
Target exit prices: 1st target: $46.30 2nd target: $45.60
The price of BUD is predicted to go up 11.79%, based on the high correlation periods with RGA. The similarity of these two price pattern on the periods is 97.49%.
BUD
RGA
Year
BUD Price Forecast($)
Potential Return(%)
2025
55.000
12.590
2026
68.000
39.200
2027
70.000
40.200
2028
75.000
53.530
2029
75.000
52.630
2030
85.000
72.980
AB InBev's worldwide scale and distribution is massive. Its top 20 brands each generate more than $1 billion per year in sales.
AB InBev has a 62% economic stake in Ambev, which has dominant volume share in several key markets, including Brazil (62%), Argentina (77%), and Canada (41%). Additionally, AB InBev has leading share in the United States (43%), and Belgium (57%).
Running with net negative working capital and cash flow conversion above 100% of net profit, ABI is a cash-generating machine, which should lead to strong shareholder returns in the long run.
TD Cowen
Price Target
$65 → $55
Upside
+12.2%
TD Cowen
Price Target
$68
Upside
+3.89%
Citigroup
Price Target
n/a
Upside
0%